SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 114 filers reported holding SEELOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,948 | -86.1% | 282,327 | -9.6% | 0.00% | -100.0% |
| Q2 2023 | $373,308 | +67.0% | 312,392 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $223,483 | -74.4% | 323,326 | -74.9% | 0.00% | -50.0% |
| Q4 2022 | $874,001 | -60.8% | 1,287,189 | -40.5% | 0.00% | -50.0% |
| Q3 2022 | $2,227,000 | +41.0% | 2,161,965 | -6.8% | 0.00% | +100.0% |
| Q2 2022 | $1,579,000 | -15.9% | 2,320,946 | +3.6% | 0.00% | 0.0% |
| Q1 2022 | $1,878,000 | +18.8% | 2,241,068 | +131.0% | 0.00% | +100.0% |
| Q4 2021 | $1,581,000 | +2008.0% | 969,993 | +3305.0% | 0.00% | – |
| Q2 2021 | $75,000 | – | 28,487 | +167470.6% | 0.00% | – |
| Q4 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |